National AI Awards 2025Discover AI's trailblazers! Join us to celebrate innovation and nominate industry leaders.

Nominate & Attend

Senior Health Economist (Bracknell)

Boehringer Ingelheim
Bracknell
1 month ago
Applications closed

Related Jobs

View all jobs

Senior Scientist, Evidence Synthesis

Senior Scientist, Evidence Synthesis

Senior Scientist, Evidence Synthesis

Senior Scientist, Evidence Synthesis

Senior Scientist, Evidence Synthesis

Senior Scientist, Evidence Synthesis

THE POSITION


The Senior Health Economist is responsible for value creation and demonstration, effectively communicating the value of an allocated product portfolio to national payers and related stakeholders, thereby removing barriers to patient access, via a proactive in-house approach to Health Economics.


Tasks & responsibilities


  • Leads the development, review and refinement of UK/Ireland National Market Access Plans for Boehringer Ingelheim products in collaboration with various internal stakeholders
  • Designs and develops optimal HTA strategy and leads all aspects of the HTA process for allocated products in UK/Ireland, to optimise HTA conditions for pipeline assets and minimise value erosion within inline brands
  • Demonstrates HE functional excellence behaviours by leading and adapting (where appropriate) Corporate HEOR materials to ensure they are fit-for-purpose to the UK/Ireland setting and comply with ABPI Code of Practice. Commissions and manages large projects with third-party vendors and both internal and external stakeholders.
  • Fosters the in-house development and training of other Boehringer Ingelheim Health Economists
  • Takes a prominent role in cross-functional Franchise teams and is a recognized authority, ensuring that Market Access is integral to brand strategy and tactics
  • Provides timely and accurate delivery of horizon scanning information on pipeline products. Ensures Market Access input during early-stage product development and assessment
  • Leads the integration and validation of payer insights into the health economic approach and deliverables (HTA and payer value proposition). Translate patient access strategy into robust health economic strategies and Boehringer Ingelheim studies. Proactively communicate actionable conclusions, recommendations, and payer value messages.

Requirements


  • At least an MSc in Health Economics or equivalent discipline
  • Good working knowledge and practical experience of all methods of economic evaluation, the requirements, and processes of HTA bodies including NICE and SMC
  • In depth technical knowledge of HE modelling and value communication & implementation using a variety of channels
  • Ability to apply these approaches to support Boehringer Ingelheim’s business objectives
  • Ability to collaborate and communicate with cross-functional teams, and to work at a strategic level within cross-functional teams
  • Experience of working within ABPI and IPHA codes of practice would be advantageous




Our Company

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more atwww.boehringer-ingelheim.com


Why Boehringer Ingelheim?

With us, you can develop your own path in a company with a culture that knows our differences are our strengths – and break new ground in the drive to make millions of lives better.

Here, your development is our priority. Supporting you to build a career as part of a workplace that is independent, authentic and bold, while tackling challenging work in a respectful and friendly environment where everyone is valued and welcomed.

Alongside, you have access to programs and groups that ensure your health and wellbeing are looked after – as we make major investments to drive global accessibility to healthcare. By being part of a team that is constantly innovating, you’ll be helping to transform lives for generations.


Want to learn more? Visithttps://www.boehringer-ingelheim.com

National AI Awards 2025

Subscribe to Future Tech Insights for the latest jobs & insights, direct to your inbox.

By subscribing, you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

How to Find Hidden Biotechnology Jobs in the UK Using Professional Bodies like the RSB, BIA, BioIndustry Association & More

The UK biotechnology sector is thriving. From cutting-edge gene therapies and synthetic biology to bio-manufacturing and agricultural innovation, the demand for skilled biotech professionals continues to grow. Yet many of the best opportunities—particularly in early-stage companies, startups, and research-intensive roles—are never listed on conventional job boards. So where do these hidden biotech jobs live? Often, they’re shared through word-of-mouth, member networks, or professional communities—especially those associated with leading biotech institutions and associations. Whether you’re a graduate looking for your first role, a research scientist ready to move into industry, or a regulatory professional seeking your next challenge, joining the right professional bodies can give you exclusive access to job leads, collaborations, and insider opportunities. In this article, we’ll show you how to strategically leverage UK-based organisations such as the Royal Society of Biology (RSB), BioIndustry Association (BIA), and Biotech and Life Sciences Networks to uncover hidden jobs and build a long-term, sustainable career in biotechnology.

How to Get a Better Biotechnology Job After a Lay-Off or Redundancy

Being made redundant from a biotechnology role can come as a shock, especially when your work involves complex research, innovation, and long development cycles. Whether due to funding cuts, mergers, shifting priorities in pharma or medtech, or economic turbulence, redundancies in biotech are becoming more common. But this doesn’t have to be the end of your career trajectory. In fact, many professionals go on to find better, more rewarding roles after a redundancy. With the UK’s biotech sector still growing rapidly across life sciences, pharmaceuticals, diagnostics, biomanufacturing, and synthetic biology, new opportunities are emerging every day. This guide will help you bounce back with purpose. From mental reset and CV refresh to recruiter outreach and sector-specific job search tips, here’s how to turn redundancy into a career upgrade.

Biotech Jobs Salary Calculator 2025: Pinpoint Your True Worth in the UK Life‑Sciences Market

Why yesterday’s salary guide won’t cut it in today’s biotech landscape “Could I earn more elsewhere?” Every life‑sciences professional has whispered that question—perhaps after seeing a colleague jump to a new start‑up for a chunky raise, or hearing that a peer at a rival pharma company pocketed a surprise bonus. Yet finding a credible benchmark in biotechnology is harder than ever. The sector morphs daily: gene‑therapy breakthroughs spawn new manufacturing lines, government funds pour into north‑of‑England cell‑&‑gene hubs, & Covid‑era mRNA expertise now permeates vaccine, oncology, & even agritech pipelines. Pay bands move with each development; a salary survey printed last year is already a museum piece. To clear the fog, BiotechnologyJobs.co.uk has reverse‑engineered a straightforward, three‑factor formula that estimates an accurate 2025 salary for UK‑based biotech professionals in seconds. Feed in your role, your region, & your seniority, and you’ll have a solid figure to anchor your next pay review or job‑offer negotiation. This article spells out the formula, spotlights the forces driving wages upward, & lays out practical steps to boost your market value over the next 90 days.